Kamada (KMDA) EBT (2012 - 2026)
Kamada's (KMDA) quarterly EBT came in at $10.2 million in Q2 2026, up 77.11% on a YoY basis from $5.8 million in Q2 2025, and up 89.0% quarter-over-quarter from $5.4 million in Q1 2026.
Analysis
Kamada (KMDA) EBT (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported EBT for 15 consecutive years, with $10.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT rose 77.11% year-over-year to $10.2 million; the trailing twelve-month figure through Jun 2026 stood at $26.7 million (up 42.13% YoY), and the FY2025 full-year result was $23.5 million, up 75.99% from the prior year.
- EBT advanced to $10.2 million in Q2 2026 per KMDA's latest filing, from $5.4 million in the prior quarter.
- Across five years, EBT topped out at $10.2 million in Q2 2026 and bottomed at -$3.9 million in Q2 2022.
- Historically, EBT has averaged $3.3 million across 5 years, with a median of $3.6 million in 2023.
- The sharpest annual moves came in 2022 and 2023: EBT slumped 517.5% in 2022, then soared 567.21% in 2023.
- Over 5 years, EBT stood at $2.9 million in 2022, then jumped by 70.54% to $5.0 million in 2023, then sank by 51.05% to $2.5 million in 2024, then jumped by 92.52% to $4.7 million in 2025, then surged by 115.23% to $10.2 million in 2026.
- According to Business Quant data, EBT over the past three periods registered $10.2 million, $5.4 million, and $4.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | 2.77 Bn |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | -10.25 Bn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | 1.39 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | 1.53 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | 542.00 Mn |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | -767.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | 132.40 Mn |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | -294.56 Mn |
| 10 | Kamada | 473.28 Mn | 403.14 Mn | 22.47 Mn | 10.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.19 Mn |
| Mar 31, 2026 | 5.39 Mn |
| Dec 31, 2025 | 4.73 Mn |
| Sep 30, 2025 | 6.37 Mn |
| Jun 30, 2025 | 5.75 Mn |
| Mar 31, 2025 | 6.61 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Sep 30, 2024 | 3.95 Mn |
| Jun 30, 2024 | 4.49 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 5.02 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | -1.80 Mn |
| Dec 31, 2022 | 2.95 Mn |
| Sep 30, 2022 | 494,000.00 |
| Jun 30, 2022 | -3.91 Mn |
| Mar 31, 2022 | -1.79 Mn |
| Dec 31, 2021 | -4.66 Mn |
| Sep 30, 2021 | -845,000.00 |